One of the key aspects of precision medicine in bile duct cancer is the identification of genetic mutations and alterations that drive tumor growth. Advances in genomic sequencing technologies have made it possible to identify specific mutations in the DNA of cancer cells with great precision. For example, mutations in genes such as IDH1, IDH2, FGFR2, and BRAF have been found in subsets of bile...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian